HCV protease inhibitor VX-222, Purity ≥98%

Cat. No.: X24-06-ZQ911

HCV protease inhibitor VX-222, Purity ≥98%

Synonym: 1026785-59-0; HCV protease inhibitor; VCH222; VX222

  • CAS Number: 1026785-59-0
  • Compound CID: 24798764
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
VX-222, soluble in DMSO and ethanol and insoluble in water, targets and inhibits the function of the hepatitis C virus protease enzyme. It targets HCV NS5B 1a and HCV NS5B 1b.
Molecular Weight
445.6
Molecular Formula
C25H35NO4S
Targets
HCV NS5B 1a: 0.94 μM; HCV NS5B 1b: 1.2 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 76 mg/mL (170.55 mM); Water: Insoluble; Ethanol: 76 mg/mL (170.55 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
VX-222 is a potential HCV NS5B polymerase inhibitor, crucial for HCV replication research.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0